Detalhe da pesquisa
1.
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60.
J Neurol Neurosurg Psychiatry
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453478
2.
Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trial.
J Neurol Neurosurg Psychiatry
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754979
3.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
4.
Meaningful cognitive change for the Minimal Assessment of Cognitive Function in Multiple Sclerosis.
Mult Scler
; : 13524585241249084, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717089
5.
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
Mult Scler
; 30(6): 707-713, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38456445
6.
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Brain
; 146(6): 2489-2501, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515653
7.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369086
8.
Comparing Natural History of Early and Late Onset Pediatric Multiple Sclerosis.
Ann Neurol
; 91(4): 483-495, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150168
9.
Risk of secondary progressive multiple sclerosis after early worsening of disability.
J Neurol Neurosurg Psychiatry
; 94(12): 984-991, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414538
10.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
11.
Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients.
Mol Psychiatry
; 27(2): 1010-1019, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650209
12.
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Mult Scler
; 29(8): 904-925, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293841
13.
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.
Mult Scler
; 29(11-12): 1363-1372, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37691493
14.
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Eur J Neurol
; 30(8): 2144-2176, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293849
15.
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Brain
; 145(8): 2796-2805, 2022 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325059
16.
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Neurol Sci
; 44(11): 4001-4011, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311951
17.
Early Predictors of 9-Year Disability in Pediatric Multiple Sclerosis.
Ann Neurol
; 89(5): 1011-1022, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598931
18.
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry.
J Neurol Neurosurg Psychiatry
; 2022 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180218
19.
Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.
Mult Scler
; 28(1): 132-138, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764197
20.
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course.
Mult Scler
; 28(1): 154-159, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34100326